175 related articles for article (PubMed ID: 32489142)
1. Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review.
Dhillon N; Oliffe JL; Kelly MT; Krist J
Am J Mens Health; 2020; 14(3):1557988320925691. PubMed ID: 32489142
[TBL] [Abstract][Full Text] [Related]
2. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
3. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
[TBL] [Abstract][Full Text] [Related]
4. A Literature Review of Cervical Cancer Screening in Transgender Men.
Gatos KC
Nurs Womens Health; 2018 Feb; 22(1):52-62. PubMed ID: 29433700
[TBL] [Abstract][Full Text] [Related]
5. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
[TBL] [Abstract][Full Text] [Related]
6. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk.
Brown B; Poteat T; Marg L; Galea JT
LGBT Health; 2017 Oct; 4(5):315-319. PubMed ID: 28876211
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives.
Agénor M; Peitzmeier SM; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
Cult Health Sex; 2016 Oct; 18(10):1192-206. PubMed ID: 27142466
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer prevention in transgender men: a review.
Weyers S; Garland SM; Cruickshank M; Kyrgiou M; Arbyn M
BJOG; 2021 Apr; 128(5):822-826. PubMed ID: 32931650
[TBL] [Abstract][Full Text] [Related]
10. Gynecologic Health Care Providers' Willingness to Provide Routine Care and Papanicolaou Tests for Transmasculine Individuals.
Shires DA; Prieto L; Woodford MR; Jaffee KD; Stroumsa D
J Womens Health (Larchmt); 2019 Nov; 28(11):1487-1492. PubMed ID: 31411513
[No Abstract] [Full Text] [Related]
11. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men.
Johnson MJ; Mueller M; Eliason MJ; Stuart G; Nemeth LS
J Clin Nurs; 2016 Dec; 25(23-24):3628-3642. PubMed ID: 27240268
[TBL] [Abstract][Full Text] [Related]
12. Six Tips for Giving Good Health Care to Anyone With a Cervix.
Sallans RK
AMA J Ethics; 2020 Feb; 22(2):E168-175. PubMed ID: 32048589
[TBL] [Abstract][Full Text] [Related]
13. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: A systematic narrative review.
Connolly D; Hughes X; Berner A
Prev Med; 2020 Jun; 135():106071. PubMed ID: 32243938
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
17. Gender Identity Disparities in Cancer Screening Behaviors.
Tabaac AR; Sutter ME; Wall CSJ; Baker KE
Am J Prev Med; 2018 Mar; 54(3):385-393. PubMed ID: 29338956
[TBL] [Abstract][Full Text] [Related]
18. Breast and Cervical Cancer Screening Disparities in Transgender People.
Oladeru OT; Ma SJ; Miccio JA; Wang K; Attwood K; Singh AK; Haas-Kogan DA; Neira PM
Am J Clin Oncol; 2022 Mar; 45(3):116-121. PubMed ID: 35195561
[TBL] [Abstract][Full Text] [Related]
19. "It Can Promote an Existential Crisis": Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals.
Peitzmeier SM; Agénor M; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
Qual Health Res; 2017 Dec; 27(14):2138-2149. PubMed ID: 28836483
[TBL] [Abstract][Full Text] [Related]
20. Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.
Berner AM; Connolly DJ; Pinnell I; Wolton A; MacNaughton A; Challen C; Nambiar K; Bayliss J; Barrett J; Richards C
Br J Gen Pract; 2021 Aug; 71(709):e614-e625. PubMed ID: 34001539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
